[Federal Register Volume 65, Number 217 (Wednesday, November 8, 2000)]
[Notices]
[Pages 67012-67013]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-28616]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Report on FDA Plan for Statutory Compliance; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
availability of a report entitled ``Report on FDA Plan for Statutory 
Compliance.'' This report satisfies provisions of the FDA Modernization 
Act of 1997 (FDAMA), which charged FDA to develop a plan for meeting 
its statutory requirements, and to report on planned versus actual 
performance.

ADDRESSES: Copies of the report may be obtained from the contact person 
at the address listed below. Persons with access to the Internet may 
obtain the report at http://www.fda.gov/oc/fdama/fdamaplnresponse/rptFY99.html.

FOR FURTHER INFORMATION CONTACT:  Bill J. Hagan, Office of Planning 
(HFP-20), Food and Drug Administration, 5600 Fishers Lane, Rockville, 
MD 20857, 301-827-5212, FAX 301-827-5225, or e-mail: [email protected].

SUPPLEMENTARY INFORMATION: FDA is announcing the availability of a 
report entitled ``Report on FDA Plan for Statutory Compliance.'' This 
report satisfies provisions outlined in section 406(b) of FDAMA, which 
charged FDA to develop a plan for meeting its

[[Page 67013]]

statutory requirements, and to report on planned versus actual 
performance. The plan was published in November 1998. This report 
identifies accomplishments against that plan. As this report shows, in 
fiscal year 1999, FDA achieved significant gains in the six FDAMA 
objectives by combining the agency's traditional principles and 
practices with new approaches. In keeping with its traditional values, 
FDA continued providing a broad spectrum of consumer protections based 
on rigorous science-based standards. To strengthen its performance, FDA 
developed partnerships with stakeholders and stimulated cooperation and 
participation by making its activities more understandable and 
accessible to stakeholders. FDA's accomplishments include the 
following:
     New drugs and biological products are being reviewed and 
released to the public in record time,
     A nationwide food safety surveillance network has now been 
established which is helping to significantly reduce food-related 
illnesses and deaths, and
     Millions of consumers have wider and more timely access to 
information about their new medications.
    FDA will continue working with Congress and our stakeholders to 
improve performance and to work towards meeting our statutory 
obligations under FDAMA.

    Dated: October 30, 2000.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 00-28616 Filed 11-7-00; 8:45 am]
BILLING CODE 4160-01-F